NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 2050-6511

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease ; volume:14 ; number:1 ; day:29 ; month:8 ; year:2013 ; pages:1 ; date:8.2013
BMC pharmacology & toxicology ; 14, Heft 1 (29.8.2013), 1, 8.2013

Creator: Thatcher, Gregory RJ

Contributor: Luo, Jia
VandeVrede, Lawren
Qin, Zhihui
Lee, Sue
Abdelhamid, Ramy
Bennett, Brian M.
Jo LaDu, Mary
Tai, Leon
Larson, John
SpringerLink (Online service)

DOI: 10.1186/2050-6511-14-S1-P72

URN: urn:nbn:de:1111-2016073154407

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 11:02 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Thatcher, Gregory RJ
Luo, Jia
VandeVrede, Lawren
Qin, Zhihui
Lee, Sue
Abdelhamid, Ramy
Bennett, Brian M.
Jo LaDu, Mary
Tai, Leon
Larson, John
SpringerLink (Online service)

Other Objects (12)

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Nanoscale structure of amyloid-β plaques in Alzheimer’s disease

Neuropathology of the Alzheimer's continuum: an update

In vivo cortical diffusion imaging relates to Alzheimer’s disease neuropathology

SMOC1 colocalizes with Alzheimer’s disease neuropathology and delays Aβ aggregation

Medin co-aggregates with vascular amyloid-β in Alzheimer’s disease

Naringenin ameliorates amyloid-β pathology and neuroinflammation in Alzheimer’s disease

Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease

Distinct amyloid-β and tau-associated microglia profiles in Alzheimer’s disease

Myelin dysfunction drives amyloid-β deposition in models of Alzheimer’s disease

Morphological and Molecular Profiling of Amyloid-β Species in Alzheimer’s Pathogenesis

Alzheimer’s disease neuropathological change three decades after iatrogenic amyloid-β transmission

Salidroside reduces neuropathology in Alzheimer’s disease models by targeting NRF2/SIRT3 pathway

Related objects

Reset password